|1.||Cross, Heide S: 10 articles (01/2012 - 06/2002)|
|2.||Kállay, Enikö: 7 articles (01/2012 - 06/2002)|
|3.||Reichrath, Jörg: 6 articles (07/2012 - 05/2004)|
|4.||Meese, Eckart: 6 articles (06/2010 - 01/2003)|
|5.||Peters, Ulrike: 5 articles (01/2015 - 10/2007)|
|6.||Badenhoop, Klaus: 5 articles (01/2014 - 05/2004)|
|7.||Fischer, Ulrike: 5 articles (06/2010 - 01/2003)|
|8.||Seifert, Markus: 5 articles (09/2009 - 05/2004)|
|9.||Lechner, Daniel: 5 articles (07/2006 - 12/2003)|
|10.||Slominski, Andrzej T: 4 articles (02/2015 - 03/2013)|
02/10/2015 - "CYP27B1 and CYP24A1 expression were significantly different between tumor and normal tissues in NSCLC. "
02/10/2015 - "Seven single nucleotide polymorphisms (SNPs) were genotyped, the expression of CYP27B1 and CYP24A1 were measured in 153 tumor samples and their associations with genotypes and patient survival were also analyzed. "
02/01/2015 - "Furthermore, CYP27B1 expression was negatively correlated with tumor cell modeling of their microenvironment. "
02/01/2015 - "The expression of CYP27B1 was positively correlated with a lower proliferation rate, lower dynamism of tumor growth and tumor infiltrating lymphocyte response. "
02/01/2015 - "CYP27B1 is expressed in normal tissues and tumors. "
|2.||Vitamin D Deficiency
02/01/2014 - "Vitamin D deficiency in BN rats correlates with maternal renal CYP24a1 upregulation followed by CYP27b1 upregulation. "
07/01/2013 - "However, vitamin D deficiency in combination with the "AC" CYP27B1 genotype appeared to inhibit the CYP27B1 expression in NK cells (p=0.03). "
10/01/2008 - "Absence of a functional VDR or the key activating enzyme, 25-OHD-1alpha-hydroxylase (CYP27B1), in mice creates a bone and growth plate phenotype that mimics humans with the same congenital disease or severe vitamin D deficiency. "
10/01/2008 - "Lack of Cyp27b1 exacerbates disease in this model, suggesting that similar effects may occur with vitamin D deficiency."
02/01/2005 - "Vitamin D deficiency resulted in an increase in both the reporter gene and CYP27B1 expression. "
|3.||Prostatic Neoplasms (Prostate Cancer)
06/01/2005 - "These studies provide the basis for a more detailed understanding of CYP27B1 repression in prostate cancer cells and could provide a novel insight in future diagnosis and treatment."
11/01/2002 - "This study suggests that the CYP27B1 gene does not play a major role as a prostate cancer susceptibility gene."
10/01/2007 - "Genotypes of CYP27B1 and CYP24A1 were not associated with prostate cancer risk. "
06/01/2005 - "First, we identify a repressive region between -997 and -1200 in the human CYP27B1 promoter following transient transfection analysis in the prostate cancer cell lines DU145, PC3 and LNCaP. "
06/01/2005 - "CYP27B1 is substantially repressed in prostate cancer cells. "
|4.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "In a case (n = 928)-control (n = 843) study of breast cancer in AA and EA women, we measured serum 25OHD levels in controls and tested associations between risk and tag single nucleotide polymorphisms (SNPs) in VDR, CYP24A1 and CYP27B1, particularly by ER status. "
07/01/2006 - "The aims of this study were to: i) assess the association between breast cancer risk and plasma 25OHD3 concentration and ii) define the significance of expression of the 25OHD activating enzyme CYP27b1 in non-malignant and malignant models of breast epithelial cells. "
01/01/2007 - "Since the down regulation of the CYP27B1 gene is tissue- and cell-type selective, a comparative study was done for the new 1alpha,25(OH)2D3-responsive regions in HEK-293 human embryonic kidney and MCF-7 human breast cancer cells that reflect tissues that, respectively, are permissive and non-permissive to the phenomenon of 1alpha,25(OH)2D3-mediated down-regulation of this gene. "
01/01/2015 - "MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1."
01/01/2010 - "Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions."
03/01/2013 - "Association studies have implicated common variants in the 12q14.1 region containing CYP27B1 in multiple sclerosis (MS). "
03/01/2014 - "No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients."
01/15/2014 - "The analysis of genetic variability in CYP27B1 and its effect on risk of multiple sclerosis (MS) has yielded conflicting results. "
01/15/2014 - "Analysis of CYP27B1 in multiple sclerosis."
03/01/2013 - "No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis."
|3.||Calcitriol Receptors (Calcitriol Receptor)
|4.||Vitamin D-Binding Protein
|5.||vitamin D 24-hydroxylase (CYP24)
|8.||Proteins (Proteins, Gene)
|9.||Factor IX (PTC)
|10.||Peroxisome Proliferator-Activated Receptors (PPAR)
|3.||Exercise Therapy (Therapy, Exercise)